Squamous cell carcinoma in situ. Photo by Klaus D. Peter via Wikimedia Commons Findings from a preclinical study show a topical cream that blocks the immune-suppressing enzyme LSD1 suppressed tumour growth in two models of cutaneous squamous cell carcinoma (cSCC). The study, published in the Journal of Clinical Investigation , describes how the cream, developed by researchers at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, prevents LSD1

The results of new Spanish research indicate that the pro-inflammatory cytokine IL-17 is central to skin aging and could potentially be...

Researchers have found that common moles on the skin contain a quantity of CD4+ T cells that could in principle be activated as a...